Charlie Scott

6PUBLICATIONS
32CO-AUTHORS
Epidemiological modellingSport and exercise nutritionBehavioural epidemiologyCharacterisation of biological macromoleculesEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 05, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

|Apr 24, 2026
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

|Mar 29, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone.

Rajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan

|Nov 06, 2025
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.

Amy Mottl, Charlie Scott, Jennifer B Green

|Sep 18, 2025
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.

Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink

|May 02, 2025
Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index: FIDELITY Post Hoc Analysis.

Peter Rossing, Andreas L Birkenfeld, Paola Fioretto

Pageof 1

Frequent Collaborators

6 joint publications

Peter Rossing

5 joint publications

Janet B McGill

4 joint publications

Hiddo J L Heerspink

4 joint publications

Muthiah Vaduganathan